Case Reports
doi: 10.1097/JCP.0b013e3181e63033.
Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome
- PMID: 20631570
- DOI: 10.1097/JCP.0b013e3181e63033
Item in Clipboard
Case Reports
Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome
J Clin Psychopharmacol.
2010 Aug.
No abstract available
Similar articles
-
Not all monoamine oxidase inhibitors are created equal.J Am Geriatr Soc. 2007 Nov;55(11):1890. doi: 10.1111/j.1532-5415.2007.01382.x. J Am Geriatr Soc. 2007. PMID: 17979910 No abstract available.
-
[Irreversible, non-selective monoamine oxidase inhibitors].Tidsskr Nor Laegeforen. 2009 Apr 16;129(8):746-8. doi: 10.4045/tidsskr.09.34296. Tidsskr Nor Laegeforen. 2009. PMID: 19373300 Norwegian.
-
Serotonin syndrome precipitated by the monoamine oxidase inhibitor linezolid.Am J Psychiatry. 2007 Feb;164(2):346-7. doi: 10.1176/ajp.2007.164.2.346b. Am J Psychiatry. 2007. PMID: 17267801 No abstract available.
-
[Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].Nervenarzt. 1996 May;67(5):339-47. Nervenarzt. 1996. PMID: 9005342 Review. German.
-
Tolerability of ziprasidone: an expanding perspective.J Clin Psychiatry. 2003;64 Suppl 19:40-9. J Clin Psychiatry. 2003. PMID: 14728089 Review.
Cited by
-
Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques.Ther Adv Psychopharmacol. 2019 Mar 11;9:2045125318818814. doi: 10.1177/2045125318818814. eCollection 2019. Ther Adv Psychopharmacol. 2019. PMID: 30886699 Free PMC article.
-
Clinically significant drug interactions with atypical antipsychotics.CNS Drugs. 2013 Dec;27(12):1021-48. doi: 10.1007/s40263-013-0114-6. CNS Drugs. 2013. PMID: 24170642 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
